Literature DB >> 22888391

Gastric Hepatoid Carcinoma Presenting Initially as GIST on CT Scan.

Baotram Tran1, James Ouellette.   

Abstract

Entities:  

Year:  2012        PMID： 22888391      PMCID： PMC3415722     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  28 in total

Review 1.  Hepatoid adenocarcinoma - review of the literature illustrated by a rare case originating in the peritoneal cavity.

Authors:  Georgia Metzgeroth; Philipp Ströbel; Tobias Baumbusch; Andreas Reiter; Jan Hastka
Journal:  Onkologie       Date:  2010-04-13

Review 2.  Palliative chemotherapy for advanced gastric cancer.

Authors:  S S Wöhrer; M Raderer; M Hejna
Journal:  Ann Oncol       Date:  2004-11       Impact factor: 32.976

3.  Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach.

Authors:  Xiaowen Liu; Yufan Cheng; Weiqi Sheng; Hongfen Lu; Xiaoli Xu; Yu Xu; Ziwen Long; Huiyan Zhu; Yanong Wang
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

4.  Hepatoid carcinoma of the ovary: characteristics of its immunoreactivity. A case report.

Authors:  J S H Tsung; P S Yang
Journal:  Eur J Gynaecol Oncol       Date:  2004       Impact factor: 0.196

5.  Hepatoid carcinoma of the pancreas: a case report and literature review of a heterogeneous group of tumors.

Authors:  Omar Hameed; Haodong Xu; Saha Saddeghi; Horacio Maluf
Journal:  Am J Surg Pathol       Date:  2007-01       Impact factor: 6.394

6.  Hepatoid adenocarcinoma of the ureter: unusual case presenting hepatic and ovarian metastases.

Authors:  Matteo Rotellini; Luca Messerini; Niceta Stomaci; Maria Rosaria Raspollini
Journal:  Appl Immunohistochem Mol Morphol       Date:  2011-10

7.  Alpha-fetoprotein production by a hepatoid adenocarcinoma of the uterus.

Authors:  R Yamamoto; H Ishikura; M Azuma; H Hareyama; S Makinoda; Y Koyama; S Nishi; S Fujimoto
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

8.  Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Authors:  Eric Van Cutsem; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Marie-Laure Risse; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

9.  Hepatoid adenocarcinoma of the stomach: a case report.

Authors:  C Ihling; H E Schaefer; U Baumgartner; U N Riede
Journal:  Gen Diagn Pathol       Date:  1995-05

10.  Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction.

Authors:  M Dank; J Zaluski; C Barone; V Valvere; S Yalcin; C Peschel; M Wenczl; E Goker; L Cisar; K Wang; R Bugat
Journal:  Ann Oncol       Date:  2008-06-16       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.